Advertisement

Genetik der Urolithiasis im Kindesalter

  • A. Hesse
  • B. Hoppe
Chapter

Zusammenfassung

Während der letzten Jahre wurden viele interessante Fortschritte auf dem Gebiet der Pathophysiologie und der Molekulargenetik der Urolithiasis gemacht. Einige der inzwischen beschriebenen molekularen Mechanismen wurden bei pädiatrischen Patienten erstmals aufgezeigt. Aufbauend auf verbesserten Kenntnissen der metabolischen Hintergtünde und der molekulargenetischen Basis der Urolithiasis, konnten schließlich wesentlich verbesserte Therapiekonzepte ausgestellt werden.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Aida K, Koishi S, Inoue M, Nakazato M, Tawata M, Onaya T (1995) Familial hyp ocalciuric hypercalcemia associated with mutation in the human Ca(2+)-sensing receptor gene. J Clin Endocrin & Metab 80(9):2594–2598Google Scholar
  2. 2.
    Akuta N, Lloyd SE, Igarashie T, Shiraga H, Matsuyama T, Yokoro S, Cox JPD, Thakker RV (1997) Mutations of CLCN5 in Japanese children with idiopathic low molecular weight proteinuria, hypercalciuria and nephrocalcinosis. Kidney Int 52:911–916PubMedGoogle Scholar
  3. 3.
    Basaklar AC, Kale N (1991) Experiences with childhood urolithiasis (report of 196 cases). Br J Urol 67:203–205PubMedGoogle Scholar
  4. 4.
    Birwé H, Hesse A (1991) High-performance liquid chromatographic determination of urinary cysteine and cystine. Clin Chim Acta 199:33–42PubMedGoogle Scholar
  5. 5.
    Bisceglia L, Calonge MJ, Dello Strologo L, Rizzoni G, de Sanctis L, Gallucci M, Beccia E, Testar X, Zorzano A, Estivill X, Zelante L, Palacin M, Gasperini P, Nunes V (1996) Molecular analysis of the cystinuria disease gene: identification of four new mutations, one large deletion, and one polymorphism. Hum Genet 98(4):447–451PubMedGoogle Scholar
  6. 6.
    Bisceglia L, Calonge MJ, Totaro A, Feliubadal¢ L, Melchionda S, Garcia J, Testar X, Galucci M, Ponzone A, Zelante L, Zorzano A, Estivil X, Gasparini P, Nunes V, Palacin M (1997) Localization, by linkage analysis, of the cystinuria type III gene to chromosome 19q13.1. Am J Hum Genet 60:611–616PubMedGoogle Scholar
  7. 7.
    Bouwens-Rombouts AG, van den Boogaard MJ, Puig JG, Mateos FA, Hennekam RC, Tilanus MG (1993) Identification of two new nucleotide mutations (HPRTUtrecht and HPRTMadrid) in exon 3 of the human hypoxanthine-guanine phosphoribosyltransferase (HPRT) gene. Hum Genet 91(5):451–454PubMedGoogle Scholar
  8. 8.
    Brühl P, Hesse A & Gu KLR (1987) Harnsteinerkrankungen im Kindesalter: Ätiologie, Diagnostik, Therapie und Metaphylaxe. Wissenschaftliche Verlagsgesellschaft mbH, StuttgartGoogle Scholar
  9. 9.
    Buckalew VM Jr. (1989) Nephrolithiasis in renal tubular acidosis. J Urol 1419(3 Pt 20):731–737PubMedGoogle Scholar
  10. 10.
    Bye S, Mallmann R, Duley J, Simmonds HA, Chen J, Tischfield JA, Sahota A (1994) Identification of a 7-basepair deletion in the adenine phosphoribosyltransferase gene as a cause of 2,8 dihydroxyadenine urolithiasis. Clin Invest 72(7):550–553Google Scholar
  11. 11.
    Calonge MJ, Gasparini P, Chillaron J, Chillon M, Gallucci M, Rousaud F, Zelante L, Testar X, Dallapiccola B, Di Silverio F (1995) Cystinuria caused by mutations in rBAT, a gene involved in the transport of cystine. Nature Genet 6(4):420–425Google Scholar
  12. 12.
    Calonge MJ, Volpini V, Bisceglia L, Rousaud F, de Sanctis L, Beccia E, Zelante L, Testar X, Zorzano A, Estivill X (1995) Genetic heterogeneity in cystinuria: the SLC3A1 gene is linked to type I but not to type III cystinuria. Proc Nat Ac Sci USA 92(21):9667–9671Google Scholar
  13. 13.
    Cameron JS, Moro F, Simmonds HA (1993) Gout, uric acid and purine metabolism in paediatric nephrology. Pediatr Nephrol 7(1):105–118PubMedGoogle Scholar
  14. 14.
    Cebellos-Picot I, Perignon JL, Hamet M, Daudon M & Kamoun P (1992) 2,8 Dihydroxyadenine urolithiasis, an underdiagnosed disease. Lancet 339:1050–1051Google Scholar
  15. 15.
    Chaabani H, Hadj-Khlil A, Ben-Dhia N, Braham H (1994) The primary hereditary form of distal renal tubular acidosis: clinical and genetic studi es in 6o-member kindred. Clin Genet 45(4):194–199PubMedGoogle Scholar
  16. 16.
    Coe FL, Nakagawa Y, Asplin J & Parks JH (1994) Role of nephrocalcin in inhibition of calcium oxalate crystallisation and nephrolithiasis (Review). Mineral & Electrolyte Metab 20(6):378–384Google Scholar
  17. 17.
    Cote G, Jequier S, Kaplan P (1989) Increased medullary echogenicity in patients with Williams syndrome. Pediatr Radial 19:481–483PubMedGoogle Scholar
  18. 18.
    Cuthbert JA (1995) Wilson’s disease: a new gene and an animal model for an old disease. J Invest Med 43(4):323–336Google Scholar
  19. 19.
    Danpure CJ, Jennings PR (1986) Peroxisomal alanine:glyoxylate aminotransferase deficiency in primary hyperoxaluria type I. FEBS Letter 201:20–24Google Scholar
  20. 20.
    Danpure CJ (1989) Recent advances in the understanding, diagnosis and treatment of primary hyperoxaluria type I. J Inner Metab Dis 12:210–224Google Scholar
  21. 21.
    Danpure CJ (1991) Molecular and clinical heterogeneity in primary hyperoxaluria type I. Am J Kidney Dis 4:366–369Google Scholar
  22. 22.
    Danpure CJ, Purdue PE, Fryer P, Griffiths S, Allsop J, Lumb MJ, Guttridge KM, Jennings PR, Scheinmann JI, Mauer SM, Davidson NO (1993) Enzymological and mutational analysis of a complex primary hyperoxaluria type I phenotype involving alanine:glyoxylate aminotransferase peroxisome-to-mitochondrion mistargeting and intraperoxisomal aggregation. Am J Hum Genet 53:417–432PubMedGoogle Scholar
  23. 23.
    Danpure CJ (1995) Advances in the enzymology and molecular genetics of primary hyperoxaluria type 1. Prospects for gene therapy. Nephrol Dial Transplant 10(Suppl 8):24–29PubMedGoogle Scholar
  24. 24.
    Finegold DN, Armitage MM, Galiani M, Matise TC, Pandian MR, Perry YM, Deka R, Ferrell RE (1994) Prelliminary localization of a gene for autosomal dominant hypoparathyroidism to chromosome 3q13. Pediatr Res 36(3):414–417PubMedGoogle Scholar
  25. 25.
    Fisher SE, Black GC, Lloyd SE, Hatchwell E, Wrong O, Thakker RV, Craig IW (1994) Isolation and partial characterization of a chloride channel gene which is expressed in kidney and is a candi­date for Dent’s disease (an X-linked hereditary nephrolithiasis). Hum Mol Gen 3(11):2053–2059PubMedGoogle Scholar
  26. 26.
    Frydman M (1990) Genetic aspects of Wilson’s disease. Journal of Gastroenterol & Hepatol 5(4)483–490Google Scholar
  27. 27.
    Frymoyer PA, Scheinmann SJ, Dunham PB, Jones DB, Hueber P, Schroeder ET (1991) X-linked recessive nephrolithiasis with renal failure. New Engl J Med 325:681–686PubMedGoogle Scholar
  28. 28.
    Fye KH, Sahota A, Hancock DC, Gelb AB, Chen J, Sparks JW, Sibley RK, Tischfield JA (1993) Adenine phosphoribosyltransferase deficiency with renal deposition of 2.8-dihydroxyadenine leading to nephrolithiasis and chronic renal failure. Arch Int Med 153(6):767–770Google Scholar
  29. 29.
    Garel L, Filiatrault D & Robitaille P (1988) Nephrocalcinosis in Barter’s syndrome. Pediatr Nephrol 2(3):315–317PubMedGoogle Scholar
  30. 30.
    Ghazali S and Barratt TM (1974) Urinary excretion of calcium and magnesium in children. Arch Dis Child 49:97–101PubMedGoogle Scholar
  31. 31.
    Gill HS and Rose GA (1986) Mild metabolic hyperoxaluria and its response to pyridoxine. Urologia Int 41(5):393–396Google Scholar
  32. 32.
    Hess B (1994) Tamm-Horsfall glycoprotein and calcium nephrolithiasis. Mineral & Electrolyte Metab 20(6):393–398Google Scholar
  33. 33.
    Hesse A, Strenge A, Bach D, Vahlensieck W (1981) Oxalate loading test for the diagnosis of oxalate hyperabsorption. In: Urolithiasis, clinical and basic research. Eds.: Smith LH, Robertson WG, Finlayson B. Plenum Press New York—London, pp 779–781Google Scholar
  34. 34.
    Hesse A, Bach D (1982) Harnsteine, Pathobiochemie und klinisch-chemische Diagnostik, Thieme, Stuttgart-New YorkGoogle Scholar
  35. 35.
    Hesse A, Classen A, Knoll M, Timmerman F & Vahlensieck W (1986) Dependence of urine composition on the age and sex of healthy subjects. Clin Chim Acta 160:79–86PubMedGoogle Scholar
  36. 36.
    Hesse A, Vahlensieck W (1986) Loading tests for diagnosis of metabolic anomalies in urinary stone farmers. Int J Urol & Nephrol 18(1):45–53Google Scholar
  37. 37.
    Hesse A, Wuzel H, Vahlensieck W (1986) The excretion of glycosaminoglycans in the urine of calcium-oxalate-stone patients and healthy persons. Urologia Int 41:81–87Google Scholar
  38. 38.
    Hesse A, Miersch WD, Classen A, Thon A, Doppler W (1988) 2,8 Dihydroxyadeninuria: laboratory diagnosis and therapy control. Urologia Int 43:174–178Google Scholar
  39. 39.
    Hesse A, Thon A, Classen A, Birw, H (1988) Diagnostic and therapy-control of inborn metabolic disorders by high performance liquid chromatography: 2,8-dihydroxyadeninuria, xanthinuria. Chromatographic 25(3):205–209Google Scholar
  40. 40.
    Hesse A, Sanders G (1988) Atlas of Infrared Spectra for the Analysis of Urinary Concrements, Thieme, Stuttgart-New YorkGoogle Scholar
  41. 41.
    Hesse A, Wuzel H, Vahlensieck W (1991) Significance of glycosaminoglycans for the formation of calcium oxalate stones. Am J Kidney Dis 17(4):414–419PubMedGoogle Scholar
  42. 42.
    Hesse A, Bongartz D, Heynck H, Berg W (1996) Measurement of urinary oxalic acid: A comparison of five methods. Clin Biochem 29(5):467–472PubMedGoogle Scholar
  43. 43.
    Hesse A, Tiselius HG, Jahnen A (1997) Urinary stones: Diagnosis, Treatment and Prevention of Recurrence. Karger, Basel—Freiburg—Paris—London—New York—NewDehli—Bangkok—Singapore—Tokyo—SydneyGoogle Scholar
  44. 44.
    Hoppe B, Gnehm HP, Wopmann M, Neuhaus T, Willi U, Leumann E (1992) Vitamin D poisoning in infants: a preventable cause of hypercalciuria and nephrocalcinosis (German) Schweiz Med Wschr 122:257–262PubMedGoogle Scholar
  45. 45.
    Hoppe B, Hesse A, Neuhaus T, Fanconi S, Forster I, Blau N, Leumann E (1993) Urinary saturation and nephrocalcinosis in preterm infants: effect of parenteral nutrition. Arch Dis Child 1993;69:299–303PubMedGoogle Scholar
  46. 46.
    Hoppe B, Neuhaus T, Superti A, Leumann E (1993) Hypercalciuria and nephrocalcinosis, a feature of Wilson’s disease. Nephron 65:460–462PubMedGoogle Scholar
  47. 47.
    Hoppe B, Danpure CJ, Rumsby G, Fyer P, Jennings PR, Blau N, Schubiger G, Neuhaus T, Leumann E (1997) A vertical (pseudodominant) pattern of inheritance in the autosomal recessive disease primary hyperoxaluria type I. Lack of relationship between genotype, enzymic phenotype and disease severity. Am J Kidney DiS 29(1):36–44PubMedGoogle Scholar
  48. 48.
    Hoppe B, Jahnen A, Bach D, Hesse A (1997) Urinary calcium-oxalate saturation in healthy infants and children. J Urol 158:557–559PubMedGoogle Scholar
  49. 49.
    Hoppe B, Hesse A, Brömme S, Rietschel E, Michalk D (1998) Urinary lithogenic and stone inhibitory substances in cystic fibrosis. Pediatr Nephrol, 12:275–279PubMedGoogle Scholar
  50. 50.
    Hoppe B, Kemper MJ, Hvizd MG, Sailer DE, Langman CB (1998) Simultaneous determination of oxalate, citrate and sulfate with ion-chromatography: normal values in childhood. Kidney Int, 53:1348–1352PubMedGoogle Scholar
  51. 51.
    Hoppe B, Kemper MJ, Bökenkamp A, Langman CB (1998) Plasma calcium-oxalate saturation in children with renal insufficiency and in children with primary hyperoxaluria. Kidney Int, 53:921–925Google Scholar
  52. 52.
    Horsford J, Saadi I, Raelson J, Goodyer PR & Rozen R (1996) Molecular genetics of cystinuria in French Canadians: identification of four novel mutations in type I patients. Kidney Int 49(5):1401–1406PubMedGoogle Scholar
  53. 53.
    Hufnagle KG, Khan SN, Penn D, Cacciarelli A, Williams P (1982) Renal calcifications: a complication of long term furosemide therapy in preterm infants. Pediatrics 70:360–363PubMedGoogle Scholar
  54. 54.
    Jacobus CH, Holick MF, Shao Q, Chen TC, Holm IA, Kolodny JM, Fuleihan GE, Seely EW (1992) Hypervitaminosis D associated with drinking milk. New Engl J Med 326(18):1173–1177PubMedGoogle Scholar
  55. 55.
    Jaeger P, Portmann L, Saunders A, Rosenberg LF, Thier SO (1986) Anticystinuric effects of glutamine and of dietary sodium restriction. New Engl J Med 315:1120–1123PubMedGoogle Scholar
  56. 56.
    Janicic N, Soliman E, Pausova Z, Seldin MF, Riviere M, Szpirer J, Szpirer C, Hendy GN (1995) Mapping of the calcium-sensing receptor gene (CASR) to human chromosome 3q13.3-21 by fluorescence in situ hybridization, and localization to rat chromosome 11 and mouse chromosome 16. Mammalian Genome 6(11):798–80lPubMedGoogle Scholar
  57. 57.
    Jiralerspong S, Patel PI (1996) Regulation of the hypoxanthine phosphoribosyl-transferase gene: in vitro and in vivo approaches. Proc Soc Ex Biol & Med 212(2):116–127Google Scholar
  58. 58.
    Kajihara S, Matsuhashi S, Yamamoto K, Kido K, Tsuji K, Tanae A, Fujiyama S, Itoh T, Tanigawa K, Uchida M (1995) Exon redefinition by a point mutation within exon 5 of the glucose-6-phospha­tase gene is the major cause of glycogen storage disease type la in Japan. Am J Hum Genet 57(3)549–555PubMedGoogle Scholar
  59. 59.
    Kelleher CL, Buckalew VM, Frederickson ED, Rhodes DJ, Conner DA, Seidman JG, Seidman CE (1998) CLCN5 mutation Ser244 Leu is associated with x-linked renal failure without x-linked recessive hypophosphatemic rickets. Kidney Int 53:31–37PubMedGoogle Scholar
  60. 60.
    Kelley WN, Levy RJ, Rosenbloom, FM, Henderson HF, Seegmiller JE (1968) Adenine phosphoribosyltansferase deficiency. J Clin Invest 47:2881Google Scholar
  61. 61.
    Kopp N, Leumann E (1995) Changing pattern of primary hyperoxaluria in Switzerland. Nephrol Dial Transplant 10:2224–2227PubMedGoogle Scholar
  62. 62.
    Laufer J, Boichis H (1989) Urolithiasis in children: current medical management. Pediatr Nephrol 3:317–331PubMedGoogle Scholar
  63. 63.
    Latta K, Brodehl J (1990) Primary hyperoxaluria type I. Europ J Pediatr 149:518–522Google Scholar
  64. 64.
    Lei KJ, Chen YT, Chen H, Wong LJ, Liu JL, McConkie-Rosell A, van Hove JL, Yeh NJ, Pan LY (1995) Genetic basis of glycogen storage disease type 1a: prevalent mutations at the glucose-6-phosphatase locus. Am J Hum Genet 57(4):766–771PubMedGoogle Scholar
  65. 65.
    Leumann EP, Niederwieser A & Fanconi A (1987) New aspects of infantile oxalosis. Pediatr Nephrol 1:531–535PubMedGoogle Scholar
  66. 66.
    Lindsjö M, Danielson BG, Fellström B, Ljunghall S (1989) Intestinal oxalate and calcium absorption in recurrent renal stone formers and healthy subjects. Scand J Nephrol 23:55–59Google Scholar
  67. 67.
    Lloyd SE, Pearce SH, Fisher SE, Steinmeyer K, Schwappach B, Scheinman SJ, Harding B, Bolino A, Devoto M, Goodyer P, Ridgen SPA, Wrong 0, Jentsch TJ, Craig IW, Thakker Ri (1996) A common molecular basis for three inherited kidney stone diseases. Nature 379(6564):398–399Google Scholar
  68. 68.
    Mansell MA (1995) Primary hyperoxaluria type 2. Nephrol Dial Transplant 10(Suppl 8):58–60PubMedGoogle Scholar
  69. 69.
    Marangella M, Petrarulo M, Cosseddu D (1994) End-stage renal failure in primary hyperoxaluria type II. New Engl J Med 330:1690(letter)PubMedGoogle Scholar
  70. 70.
    Marcus S, Christensen E, Malm G (1993) Molecular analysis of the mutations in five unrelated patients with the Lesch-Nyhan syndrome. Hum Mutation 2(6):473–477Google Scholar
  71. 71.
    Mari A, Amati F, Mingarelli R, Gianotti A, Sebastio G, Colloridi V, Novelli G, Dallpiccola B (1995) Analysis of the elastin gene in 60 patients with clinical diagnosis of Williams syndrome. Hum Genet 96(4):444–448PubMedGoogle Scholar
  72. 72.
    Matthews LA, Doershuk CF, Stern RC, Resnick MI (1996) Urolithiasis in cystic fibrosis. J Urol 155(5)1563–1564PubMedGoogle Scholar
  73. 73.
    Miller LA, Stapleton FB (1985) Urinary citrate excretion in children with hypercalciuria. J Pediatr 107(2):263–266PubMedGoogle Scholar
  74. 74.
    Minatogawa Y, Tone S, Allsop J, Purdue PE, Takada Y, Danpure CJ, Kido R (1992) A serine-tophenylalanine substitution leads to loss of alanine:glyoxyolate aminotransferase catalytic activity and immunoreactivity in a patient with primary hyperoxaluria type I. Hum Mol Genet 1:643–644PubMedGoogle Scholar
  75. 75.
    Misselwitz J, Hesse V (1990) Nephrocalcinosis, hypercalciuria and elevated serum levels of 1,25(OH)2D in children. Acta Paediatr Scand 79:637–643PubMedGoogle Scholar
  76. 76.
    Nickerson E, Greenberg F, Keating MT, McCaskill C, Shaffer LG (1995) Deletions of the elastin gene at 7q11.23 occur in approximately 90% of patients with Williams syndrome. Am J Hum Genet 56(5):1156–1161PubMedGoogle Scholar
  77. 77.
    Nishiyama K, Funai T, Katafuchi R, Hattori F, Onoyama K, Ichiyama A (1991) Primary hyperoxaluria type I due to a point mutation of T to C in the coding region of the serine:pyruvat aminotransferase gene. Biochem Biophys Res Commun 176:1093–1099PubMedGoogle Scholar
  78. 78.
    Parks JH, Coe FL (1986) A urinary calcium-citrate index for the evaluation of nephrolithiasis. Kidney Int 30:85–90PubMedGoogle Scholar
  79. 79.
    Pearce SH, Williamson C, Kifor O, Bai M, Coulthard MG, Davies M, Lewis-Barned N, McCredie D, Powell H, Kendall-Taylor P, Brown EM, Thakker RV (1996) A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor. New Engl J Med 335(15):1115–1122PubMedGoogle Scholar
  80. 80.
    Perez Jurado LA, Li X, Francke U (1995) The human calcitonin receptor gene (CALCR) at 7q21.3 is outside the deletion associated with the Williams syndrome. Cytogenet Cell Genet 70(3-4)246–249PubMedGoogle Scholar
  81. 81.
    Polinsky MS, Kaiser BA, Baluarte HJ (1987) Urolithiasis in childhood. Pediatr Clin North Am 34(3)683–710PubMedGoogle Scholar
  82. 82.
    Pook MA, Wrong O, Wooding C, Norden AG, Feest TG, Thakker RV (1993) Dent’s disease, a renal Fanconi syndrome with nephrocalcinosis and kidney stones, is associated with a microdeletion involving DXS255 and maps to chromosome XP11.22. Hum Mot Genet 2 (12):2129–2134Google Scholar
  83. 83.
    Pras E, Arber N, Aksentijevitsch I, Katz G, Schapiro JM, Prosen L, Gruberg L, Harel D, Liberman U, Weissenbach J (1994) Localization of a gene causing cystinuria to chromosome 2p. Nat Genet 6(4)415–419PubMedGoogle Scholar
  84. 84.
    Pras E, Raben N, Golomb E, Arber N, Aksentijevitsch I, Schapiro JM, Harel D, Katz G, Liberman U, Pras M (1995) Mutations in the SLC3A1 transporter gene in cystinuria. Am J Hum Genet 56(6):1297–1303PubMedGoogle Scholar
  85. 85.
    Preminger GM, Sakhaee K, Skurla C, Pak CYC (1985) Prevention of recurrent calcium stone formation with potassium citrate therapy in patients with distal renal tubular acidosis. J Urol 134:20–24PubMedGoogle Scholar
  86. 86.
    Pronicka E, Rowinska E, Kulczycka H, Lukaszkiewicz J, Lorenc R, Janas R (1997) Persistent hypercalciuria and elevated 25-hydroxyvitamin D3 in children with infantile hypercalcemia. Pediatr Nephrol 11(1):2–6PubMedGoogle Scholar
  87. 87.
    Purdue PE, Takada Y, Danpure CJ (1990) Identification of mutations associated with peroxisome to mitochondrion mistargeting of alanine/glyoxylate aminotransferase in primary hyperoxaluria type I. J Cell Biol 111:2341–2351PubMedGoogle Scholar
  88. 88.
    Purdue PE, Lumb MJ, Allsop J, Danpure CJ (1991) An intronic duplication in the alanine:glyoxylate aminotransferase gene facilitates identification of mutations in compound heterozygote patients with primary hyperoxaluria type I. Hum Genet 87:394–396PubMedGoogle Scholar
  89. 89.
    Purdue PE, Lumb MJ, Fox M, Griffo G, Hamon-Benais C, Povey S, Danpure CJ (1991) Characterisation and chromosomal mapping of a genomic clone encoding human alanine:glyoxylate aminotransferase. Genomics 10:34–42PubMedGoogle Scholar
  90. 90.
    Purdue PE, Lumb MJ, Allsop J, Minatogawa Y, Danpure CJ (1992) A glycine-to-glutamate substitution abolishes alanine:glyoxylate aminotransferase catalytic activity and immunoreactivity in a patient with primary hyperoxaluria type I. Genomics. 13:215–218PubMedGoogle Scholar
  91. 91.
    Ragavan VV, Smith JE, Bilezikian JP (1982) Vitamin A toxicity and hypercalcemia. Am J Med Sci 283(3):161–164PubMedGoogle Scholar
  92. 92.
    Reinhart SC, Norden AG, Lapsley M, Thakker RV, Pang J, Moses AM, Frymoyer PA, Favus MJ, Hoepner JA, Scheinman SJ (1995) Characterization of carrier females and affected males with X-linked recessive nephrolithiasis. J Am Soc Nephrol 5(7):1451–1461PubMedGoogle Scholar
  93. 93.
    Renwick PJ, Birley AJ, McKeown CM, Hulten M (1995) Southern analysis reveals a large deletion at the hypoxanthine phosphoribosyltransferase locus in a patient with Lesch-Nyhan syndrome. Clin Genet 48(2):80–84PubMedGoogle Scholar
  94. 94.
    Restaino I, Kaplan BS, Stanley C, Baker L (1993) Nephrolithiasis, hypocitraturia, and a distal renal tubular acidification defect in type I glycogen storage disease. J Pediatr 122(3):392–396PubMedGoogle Scholar
  95. 95.
    Rose GA (1988) Mild metabolic hyperoxaluria. A new syndrome. In: Oxalate metabolism in rela­tion to urinary stone. ed.: Rose GA, Springer Verlag London, pp 121–130Google Scholar
  96. 96.
    Rosenberg LE, Downing SJ, Durant JL, Segal S (1966) Cystinuria: biochemical evidence for three genetically distinct diseases. Clin Invest 45:365–371Google Scholar
  97. 97.
    Ryall RL (1996) Glycosaminoglycans, proteins, and stone formation: adult themes and child’s play. Pediatr Nephrol 10(5):656–666PubMedGoogle Scholar
  98. 98.
    Rumsby G, Jones R, Danpure CJ, Samuell CT (1992) TaqI polymorphism of the alanine:glyoxylate aminotransferase (AGXT) locus. Hum Mol Genet 1:350PubMedGoogle Scholar
  99. 99.
    Rumbsy G, Mandel H, Avery C, Geraerts A (1995) Polymorphisms in the alanine:glyoxylate aminotransferase gene and their clinical application to the prenatal diagnosis of primary hyperoxaluria type 1. Nephrol Dial Transplant 10[Suppl 8]:30–32Google Scholar
  100. 100.
    Rytkonen EM, Halila R, Laan M, Saksela M, Kallioniemi OP, Palotis A, Raivio KO (1995) The human gene for xanthine dehydrogenase (XDH) is localized on chromosome band 2q22. Cytogenet Cell Genet 68(1–2):61–63PubMedGoogle Scholar
  101. 101.
    Sahota A, Chen J, Boyadjiev SA, Gault MH, Tischfield JA (1994) Missense mutation in the adenine phosphoribosyltransferase gene causing 2,8 dihydroxyadenine urolithiasis. Hum Mol Genet 3(5):817–818PubMedGoogle Scholar
  102. 102.
    Sakhaee K, Williams RH, Oh MS, Padalino P, Adams-Huet B, Whitson P, Pak CYC (1993) Alkali absorption and citrate excretion in calcium nephrolithiasis. J Bone Min Res 8(7):789–794Google Scholar
  103. 103.
    Scheinmann SJ, Pook MA, blooding C, Pang JT, Frymoyer PA, Thakker RV (1993) Mapping the gene causing X-linked recessive nephrolithiasis to Xp11.22 by linkage studies. J Clin Invest 91(6):2351–2357Google Scholar
  104. 104.
    Scheinman SJ (1998) X-linked hypercalciuric nephrolithiasis: clinical syndromes and chloride channel mutations. Kidney Int 53:3–17PubMedGoogle Scholar
  105. 105.
    Sculley DG, Dawson PA, Emmerson BT, Gordon RB (1992) A review of the molecular basis of hypoxanthine-guanine phosphoribosyltransferase (HPRT) deficiency. Hum Genet 90(3):195–207PubMedGoogle Scholar
  106. 106.
    Simon DB, Karet FE, Hamdan JM, DiPietro A, Sanjad SA, Lifton RP (1996) Bartter’s syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl cotransporter NKCC2. Nat Genet 13(2):183–188PubMedGoogle Scholar
  107. 107.
    Sliman GA, Winters WD, Shaw DW, Avner ED (1995) Hypercalciuria and nephrocalcinosis in the oculocerebrorenal syndrome. J Urol 153(4):1244–1246PubMedGoogle Scholar
  108. 108.
    Stapleton FB, Noe HN, Jerkins G, Roy III S (1982) Urinary excretion of calcium following an oral calcium loading test in healthy children. Pediatr 69(5):594–597Google Scholar
  109. 109.
    Strauwen P, Hesse A, Thon A, Behrend H (1989) Xanthinuria with nephrolithiasis in infancy. Aktuelle Urologie 20(4):218–222Google Scholar
  110. 110.
    Takada Y, Kaneko N, Esumi H, Purdue PE, Danpure CJ (1990) Human peroxisomal L-alanine:glyoxylate aminotransferase. Evolutionary loss of a mitochondrial. targeting signal by point mutation of the initiation codon. Biochem J 268:517–520PubMedGoogle Scholar
  111. 111.
    Tatibana M, Kita K, Taira M, Ishijima S, Sonoda T, Ishizuka T, lizasa T, Ahmad I (1995) Mammalian phosphoribosyl-pyrophosphate synthetase [Review]. Adv Enzyme Regulation 35:229–249Google Scholar
  112. 112.
    von Schnakenburg C, Rumsby G (1997) Primary hyperoxaluria type 1: a cluster of new mutations in exon 7 of the AGXT gene. J Med Genet 34:489–492Google Scholar
  113. 113.
    von Schnakenburg C, Weir T, Rumsby G (1997) Linkage of microsatelites to the AGXT gene on chromosome 2q37.3 and their role in prenatal diagnosis of primary hyperoxaluria. Ann Hum Genet 61:365–368Google Scholar
  114. 114.
    von Schnakenburg C, Hulton SA, Milford DV, Roper HP, Rumsby G (1998) Variable presentation of primary hyperoxaluria type 1 in 2 patients homozygous for a novel combined deletion and insertion mutation in exon 8 of the AGXT gene. Nephron 70:1–4Google Scholar
  115. 115.
    Wartenfeld R, Golomb E, Katz G, Bale SJ, Goldman B, Pras M, Kastner DL, Pras E (1997) Molecular Analysis of cystinuria in Lybian Jews: exclusion of the SLC3A1 gene and mapping of a new locus on 19q. Am J Hum Genet 60:617–624PubMedGoogle Scholar
  116. 116.
    Williams HE, Smith LH (1968) A new genetic variant of primary hyperoxaluria. New Engl J Med 278:5:233PubMedGoogle Scholar
  117. 117.
    Williams HE, Wandzilak TE (1989) Oxalate synthesis, transport and the hyperoxaluric syndromes. J Urol 141:742–747PubMedGoogle Scholar
  118. 118.
    Xu P, Zhu XL, Huecksteadt TP, Brothman AR, Hoidal JR (1994) Assignment of human xanthine dehydrogenase gene to chromosome 2p22. Genomics 23(1):289–291PubMedGoogle Scholar
  119. 119.
    Zhang XX, Rozen R, Hediger MA, Goodyer P, Eydoux P (1994) Assignment of the gene for cystinuria (SLC3A1) to human chromosome 2p21 by flourescence in situ hybirdization. Genomics 24(2):413–414PubMedGoogle Scholar
  120. Cramer SD, Lin K, Ferree PM, Holmes RP (in press) Characterization of the PH 2 gene: protein and genomic structure of D-glycerate dehydrogenase in humans. Proceedings of the 5th workshop on primary hyperoxaluria. Zurich, Switzerland. Nephrol Dial Transplant, in pressGoogle Scholar
  121. Cregeen D, Rumsby G (in press) Characterization of human hydroxy-pyruvate reductase. Proceedings of the 5th workshop on primary hyperoxaluria. Zurich, Switzerland. Neprhrol Dial Transplant, in pressGoogle Scholar
  122. Monico G, Milliner DS, Wilson DM, Rumsby G (in press) Atypical primary hyperoxaluria: PH type III? Proceedings of the 5th workshop on primary hyperoxaluria. Zurich, Switzerland. Nephrol Dial Transplant, in pressGoogle Scholar
  123. Neuhaus TJ, Blau N, Leumann EP (in press) Primary hyperoxaluria (PH) not type 1 or 2 in two pediatric patients. Proceedings of the 5th workshop on primary hyperoxaluria. Zurich, Switzerland. Nephrol Dial Transplant, in pressGoogle Scholar
  124. 124.
    Sidhu H, Hoppe B, Hesse A, Tenbrock K, Brömme S, Rietschel E, Peck AB (1998) Abscence of oxalobacter formigenes in cystic fibrosis patients: a risk factor for hyperoxaluria. Lancet 352:1026–1030PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2000

Authors and Affiliations

  • A. Hesse
  • B. Hoppe

There are no affiliations available

Personalised recommendations